NDC 0409-3177-16 - Lidocaine Hydrochloride and Epinephrine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-3177
- Requested NDC
- 0409-3177-16
- Package NDCs from labels
- 0409-3177-16, 0409-3177-01
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine Hydrochloride and Epinephrine - Hospira, Inc. | Hospira, Inc. | 2026-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine Hydrochloride and Epinephrine - Henry Schein, Inc. | Henry Schein, Inc. | 2026-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine Hydrochloride and Epinephrine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-3177-01 | Lidocaine Hydrochloride and Epinephrine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 34 | |
| 0409-3177-16 | Lidocaine Hydrochloride and Epinephrine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 34 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-3177-01 | ML - Milliliter | 0409-3177 | a8145ba7-4c9a-4454-a32d-f28a5fa6fd75 | 1 | 2012-07-24 |
| 0409-3177-16 | ML - Milliliter | 0409-3177 | e0a8e71a-341d-4bb2-be08-4f7062e269d9 | 1 | 2020-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Epinephrine | EPINEPHRINE | Sportpharm LLC | a8e98483-9404-43bc-8800-b827c63c5134 | 2026-10-12 | Warnings, Adverse reactions | YKH834O4BH |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Theraworx PM Nighttime Maximum Strength Pain Relief | LIDOCAINE HYDROCHLORIDE | AVADIM HOLDINGS, INC. | bc8cb476-9a47-47b3-ad78-a6ecec9ee66f | 2026-10-08 | Warnings | V13007Z41A |
| Theraworx Pain Relief Roll- On- Lidocaine | LIDOCAINE HYDROCHLORIDE | AVADIM HOLDINGS, INC. | b4ce3876-f9e3-43ca-810b-75fbe6f887b6 | 2026-10-08 | Warnings | V13007Z41A |
| PAIN RELIEF Gel-Roll On | LIDOCAINE HYDROCHLORIDE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 5d51de1a-2166-4417-e063-6394a90adce5 | 2026-10-08 | Warnings | V13007Z41A |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Safco Dental Supply Co | 6721c3ab-c37f-4504-aebc-0103c56ed567 | 2026-10-08 | Warnings, Adverse reactions | V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 55a8372e-70d6-4b70-ac95-5226d0f5812a | 2026-10-07 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 5b74b6f4-f26f-4243-8060-cd1777907984 | 2026-10-07 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Sandoz Inc. | dc476ebd-fd57-41c3-a649-7185a784a39f | 2026-10-06 | Warnings, Adverse reactions | V13007Z41A |
| Nervive Pain Relieving | LIDOCAINE HCL AND MENTHOL | The Procter & Gamble Manufacturing Company | 32f8d0f3-d18d-1a45-e063-6294a90a6ad3 | 2026-10-05 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 5692e28d-559c-4b6a-8421-fa85d7155818 | 2026-10-05 | Warnings, Adverse reactions | ANDA089646 1010759 YKH834O4BH V13007Z41A |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.